Obidoxime: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:Obidoxime}} | |||
== | == Overview == | ||
Obidoxime is a [[ | [[File:Obidoxime_skeletal.svg|thumb|right|Skeletal structure of Obidoxime]] | ||
'''Obidoxime''' is a chemical compound used as an [[oxime]] in the treatment of [[organophosphate poisoning]]. It is a member of the [[oxime]] family, which are compounds that can reactivate [[acetylcholinesterase]] that has been inhibited by [[organophosphates]]. | |||
==Mechanism of Action== | == Mechanism of Action == | ||
Obidoxime works by | Obidoxime works by binding to the [[acetylcholinesterase]] enzyme that has been phosphorylated by an [[organophosphate]]. The oxime group in Obidoxime has a high affinity for the phosphorus atom in the organophosphate, allowing it to cleave the bond between the enzyme and the organophosphate, thereby reactivating the enzyme. This process restores the normal function of [[acetylcholinesterase]], which is to break down [[acetylcholine]] in the [[synaptic cleft]]. | ||
== | == Clinical Use == | ||
Obidoxime is used in the treatment of poisoning | Obidoxime is used in conjunction with [[atropine]] in the treatment of [[organophosphate poisoning]]. While atropine acts as an [[antimuscarinic]] agent to counteract the effects of excess [[acetylcholine]], Obidoxime works to restore the activity of [[acetylcholinesterase]]. This dual approach is critical in managing the symptoms of [[organophosphate poisoning]], which include [[muscle weakness]], [[respiratory distress]], and [[seizures]]. | ||
== | == Pharmacokinetics == | ||
Obidoxime is typically administered intravenously due to its poor oral bioavailability. Once in the bloodstream, it is distributed throughout the body and can cross the [[blood-brain barrier]] to some extent, allowing it to act on central nervous system [[acetylcholinesterase]]. The compound is metabolized in the liver and excreted primarily through the kidneys. | |||
== | == Safety and Side Effects == | ||
The use of Obidoxime can be associated with several side effects, including [[nausea]], [[vomiting]], [[dizziness]], and [[headache]]. In some cases, it may cause [[hypertension]] or [[tachycardia]]. It is important to monitor patients closely during treatment to manage any adverse effects that may arise. | |||
== Related Pages == | |||
* [[Organophosphate poisoning]] | * [[Organophosphate poisoning]] | ||
* [[Acetylcholinesterase]] | * [[Acetylcholinesterase]] | ||
* [[Atropine]] | |||
* [[Oxime]] | |||
[[Category:Antidotes]] | [[Category:Antidotes]] | ||
[[Category: | [[Category:Organophosphate poisoning treatments]] | ||
Latest revision as of 12:08, 15 February 2025
Overview[edit]
Obidoxime is a chemical compound used as an oxime in the treatment of organophosphate poisoning. It is a member of the oxime family, which are compounds that can reactivate acetylcholinesterase that has been inhibited by organophosphates.
Mechanism of Action[edit]
Obidoxime works by binding to the acetylcholinesterase enzyme that has been phosphorylated by an organophosphate. The oxime group in Obidoxime has a high affinity for the phosphorus atom in the organophosphate, allowing it to cleave the bond between the enzyme and the organophosphate, thereby reactivating the enzyme. This process restores the normal function of acetylcholinesterase, which is to break down acetylcholine in the synaptic cleft.
Clinical Use[edit]
Obidoxime is used in conjunction with atropine in the treatment of organophosphate poisoning. While atropine acts as an antimuscarinic agent to counteract the effects of excess acetylcholine, Obidoxime works to restore the activity of acetylcholinesterase. This dual approach is critical in managing the symptoms of organophosphate poisoning, which include muscle weakness, respiratory distress, and seizures.
Pharmacokinetics[edit]
Obidoxime is typically administered intravenously due to its poor oral bioavailability. Once in the bloodstream, it is distributed throughout the body and can cross the blood-brain barrier to some extent, allowing it to act on central nervous system acetylcholinesterase. The compound is metabolized in the liver and excreted primarily through the kidneys.
Safety and Side Effects[edit]
The use of Obidoxime can be associated with several side effects, including nausea, vomiting, dizziness, and headache. In some cases, it may cause hypertension or tachycardia. It is important to monitor patients closely during treatment to manage any adverse effects that may arise.
